Acadian Asset Management
ALBO

Acadian Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Acadian Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,847
Closed -$313K – 2426
2020
Q2 		$313K Sell
11,847
-3,281
-22% -$77.4K ﹤0.01% 1344
2020
Q1 		$247K Buy
+15,128
New +$333K ﹤0.01% 1151
2019
Q2 		– Sell
-5,087
Closed -$164K – 2099
2019
Q1 		$164K Sell
5,087
-2,326
-31% -$62.6K ﹤0.01% 1405
2018
Q4 		$182K Sell
7,413
-1,100
-13% -$29.1K ﹤0.01% 1137
2018
Q3 		$281K Buy
8,513
+3,868
+83% +$127K ﹤0.01% 1012
2018
Q2 		$165K Buy
+4,645
New +$150K ﹤0.01% 1134
2016
Q3 		– Sell
-1,246
Closed -$12K – 1587
2016
Q2 		$12K Buy
1,246
+1,208
+3,179% +$13.3K ﹤0.01% 1203
2016
Q1 		$0 Hold
38
– – ﹤0.01% 1521
2015
Q4 		$0 Buy
+38
New +$393 ﹤0.01% 1538

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Acadian Asset Management's ALBO Position: Q3 2020 in Review

Acadian Asset Management sold out of Albireo Pharma Inc (ALBO) in Q3 2020, closing a stake of 11,847 shares — an estimated $313K sold.

Acadian Asset Management first reported a position in ALBO in Q4 2015 and held it in 9 quarters. The position peaked at $313K in Q2 2020. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2020.

  • Acadian Asset Management reported no remaining Albireo Pharma Inc position as of Q3 2020 after selling out during the quarter.
  • Acadian Asset Management sold 11,847 Albireo Pharma Inc shares in Q3 2020, an estimated $313K.
  • Acadian Asset Management first reported a position in Albireo Pharma Inc in Q4 2015 and held it in 9 quarters.
  • Acadian Asset Management's Albireo Pharma Inc position peaked at $313K in Q2 2020.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2020.

Based on Acadian Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.